Log in to save to my catalogue

Long-term effect and reasons for switching and combining device-aided therapies in Parkinson’s Disea...

Long-term effect and reasons for switching and combining device-aided therapies in Parkinson’s Disea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153913560

Long-term effect and reasons for switching and combining device-aided therapies in Parkinson’s Disease

About this item

Full title

Long-term effect and reasons for switching and combining device-aided therapies in Parkinson’s Disease

Author / Creator

Publisher

Poland: Wydawnictwo Via Medica

Journal title

Neurologia i neurochirurgia polska, 2025-01, Vol.59 (2), p.111-126

Language

English

Formats

Publication information

Publisher

Poland: Wydawnictwo Via Medica

More information

Scope and Contents

Contents

In the advanced stages of Parkinson's disease (PD), when standard drug adjustments fail to sufficiently improve patients' quality of life, device-aided therapies (DATs) such as deep brain stimulation (DBS), continuous subcutaneous apomorphine infusion (CSAI), levodopa-carbidopa intestinal gel infusion (LCIG), levodopa-carbidopa-entacapone intestina...

Alternative Titles

Full title

Long-term effect and reasons for switching and combining device-aided therapies in Parkinson’s Disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3153913560

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153913560

Other Identifiers

ISSN

0028-3843

E-ISSN

1897-4260

DOI

10.5603/pjnns.102858

How to access this item